#ISSAD2026
Mejorar la vigilancia de infecciones neonatales es clave para avanzar en vacunas maternas.

En #ISSAD2026, #PROTECTnetwork compartió avances en sistemas de registro de embarazos y vigilancia del GBS en África.

🟠 https://tinyurl.com/47jv8c65

cc  @globalhealthedctp3.bsky.social
ISSAD 2026: PROTECT partners contribute to maternal vaccine research agenda in Africa — PROTECT
Between 22 and 24 February, the International Symposium on ‘Streptococcus agalactiae’ Disease took place in Nairobi, Kenya. PROTECT partners were strongly represented and contributed to the event with insights from all key aspects of PROTECT’s research: pregnancy registry development, GBS disease su
tinyurl.com
March 12, 2026 at 2:04 PM
#ISSAD2026 was such an amazing conference! Honored to continue the fight against GBS disease with everyone there. Many thanks to the organizers! Looking forward to the next ISSAD already!
Now that our #ISSAD2026 delegates are back home and settled into their routines, we want to say a huge THANK YOU for making the 4th International Symposium on Streptoccocus agalactiae disease so impactful.

#GBS #ISSAD2026
March 10, 2026 at 4:25 PM
Now that our #ISSAD2026 delegates are back home and settled into their routines, we want to say a huge THANK YOU for making the 4th International Symposium on Streptoccocus agalactiae disease so impactful.

#GBS #ISSAD2026
March 10, 2026 at 8:50 AM
At #ISSAD2026, partners from the #PROTECTnetwork presented work on GBS surveillance, pregnancy registries and vaccine confidence research across four African countries.

Supported by @globalhealthedctp3.bsky.social.

🟠 https://tinyurl.com/47jv8c65

#GlobalHealth
ISSAD 2026: PROTECT partners contribute to maternal vaccine research agenda in Africa — PROTECT
Between 22 and 24 February, the International Symposium on ‘Streptococcus agalactiae’ Disease took place in Nairobi, Kenya. PROTECT partners were strongly represented and contributed to the event with insights from all key aspects of PROTECT’s research: pregnancy registry development, GBS disease su
tinyurl.com
March 10, 2026 at 8:31 AM
We are honored to have our CEO Marti Perhach on the Parent Voice Committee for the #ISSAD2026 Global Conference on GBS in Nairobi, Kenya Feb 23-25 along with Oliver and Jane Plumb of Group B Strep Support in the UK and Julie Nyanchama of the Kenya Medical Research Institute.
February 25, 2026 at 9:35 PM
Plenary 5 at #ISSAD2026 has taken us From Evidence to Action. We’re moving beyond the lab to talk about how we actually reach the mothers and babies who need these vaccines most.

Because a vaccine only works if it's accessible, sustainable, and safe for everyone.

#ISSAD #GlobalHealth
February 24, 2026 at 2:52 PM
The science of GBS vaccines is advancing rapidly, but how do we implement them? In Plenary 4, we look at the evidence and economics behind the rollout.

#ISSAD2026 #GBS #GlobalHealth
February 24, 2026 at 10:36 AM
Plenary 3 at #ISSAD2026 has the architects of the next generation of maternal immunisation.

From the lab bench to phase trials, this is where the future of neonatal protection is being written.

#ISSAD2026 #VaccineDevelopment #GBS #GlobalHealth
February 24, 2026 at 9:45 AM
Plenary 1 at #ISSAD2026 is diving deep into the Disease Burden & Surveillance of Group B Strep. We’re moving beyond the basics to look at infant impact, adult disease, and the genetic "fingerprints" of GBS across the globe.

From Evidence to Action.

#ISSAD2026 #GBS #FromEvidenceToAction
February 23, 2026 at 8:16 AM
#ISSAD2026 is officially underway.

The fight against Group B Strep is in full swing, chaired by Dr Hellen Barsosio and supported by @kemri_ke and Liverpool School of Tropical Medicine.

Our official media partner is @willowhealthmedia

#FromEvidencetoAction #GBS #ISSAD
February 23, 2026 at 6:57 AM
How can we improve GBS diagnosis at the point of care? Nexsen Bio’s Prof. Vipul Bansal will be at #ISSAD2026

Session: Plenary C: Advancements in Diagnostics
Speaker: Prof. Vipul Bansal
Time: Tue, 24th Feb, 4:00 PM EAT
Venue: Hyatt Regency Westlands Nairobi (Muthithu)

#ISSAD #GBS #MaternalHealth
February 21, 2026 at 8:14 AM
Based right here in Kenya at the KEMRI-Wellcome Trust Research Programme in Kilifi, Prof. Anthony Scott is a world-renowned medical epidemiologist.

See you at #ISSAD2026!
📅23 - 25 February, 2026
📍Nairobi, Kenya

#ISSAD #GBS #WHOSAGE #GlobalHealth #MaternalHealth
February 18, 2026 at 3:54 PM
Great to see the PROTECT network featured at #ISSAD2026! We are proud to support this project advancing Group B Streptococcus (GBS) disease burden estimation, surveillance, and maternal vaccines confidence.🤝
February 17, 2026 at 4:10 PM
Will you be attending #ISSAD2026?

Make sure to connect with the #PROTECTnetwork & learn about the partners’ work on #GBS disease burden estimation, surveillance & #MaternalVaccines confidence.

Find details here➡️ tinyurl.com/3ucjhwsk

@issadgbs.bsky.social @globalhealthedctp3.bsky.social
Meet PROTECT at ISSAD 2026 — PROTECT
This year’s International Symposium on ‘Streptococcus agalactiae’ Disease (ISSAD) is an exciting opportunity for all GBS researchers to share their recent work and connect with leaders in GBS research...
tinyurl.com
February 17, 2026 at 1:07 PM
As a member of WHO SAGE, Prof. Fiona Russell doesn't just study vaccines, she helps decide how they are used to save lives globally.

Find her at #ISSAD2026
📅23 - 25 February, 2026
📍Nairobi, Kenya

#ISSAD #GBS #WHOSAGE #GlobalHealth #MaternalHealth
February 16, 2026 at 5:20 AM
Dr. Karen Puopolo’s career is in translating basic science into clinical practice.

Most notably, Dr. Puopolo has been instrumental in leading the revised U.S. national guidance for managing infants at risk for GBS disease.

Find her at #ISSAD2026

#ISSAD #GBS #MaternalHealth
February 13, 2026 at 1:06 PM
Prof. Jane Daniels is the mind behind GBS3; one of the largest GBS clinical trials. Her work is answering the question: Should we test every mother for GBS, or stick to risk-factor strategies?

Don't miss her session at #ISSAD2026

📅23 - 25 February, 2026
📍Nairobi, Kenya
February 12, 2026 at 12:25 PM
Dr. Gaurav Kwatra will be at #ISSAD2026.

He has led multi-country studies across Africa and South Asia, making his insights into the immunology of mothers and newborns vital for our mission.

Find him at #ISSAD2026

#ISSAD #WHO #GBS #VaccineDevelopment #GlobalHealth
February 12, 2026 at 7:21 AM
By partnering with KMA, #ISSAD2026 strengthens its ties with local clinicians who are at the heart of patient care.
February 11, 2026 at 11:03 AM
Kenya Medical Association (KMA) are in #ISSAD2026 with a mission to champion the welfare of doctors and the health of the public.

We look forward to a symposium enriched by the expertise of Kenya’s medical professionals.

#ISSAD2026 #KMA #PublicHealth #GBS
February 11, 2026 at 11:03 AM
Prof. Violet Naanyu is a speaker at #ISSAD2026!

She is a champion of community-engaged research and human-centered design, ensuring that global health solutions are built alongside the people they serve.

#ISSAD #MaternalHealth #PublicHealth
February 11, 2026 at 10:04 AM
Registration for #ISSAD2026 is officially CLOSED!

We are overwhelmed by the incredible response from the scientific and medical community. Thank you to everyone who joins us in the fight against Group B Strep.

See you in the green city under the sun!

#ISSAD #GlobalHealth #Nairobi
February 11, 2026 at 6:08 AM
Dr. Ignacio Esteban is a pediatrician and epidemiologist whose career has been defined by a commitment to maternal and neonatal health.

Welcome to the #ISSAD2026 lineup, Ignacio! 👏

📅23 - 25 February, 2026
📍Nairobi, Kenya

#ISSAD #MaternalHealth #GBS #NewbornSafety
February 10, 2026 at 9:04 AM
From groundbreaking clinical trials to national surveillance, KEMRI has been In Search of Better Health for over 40 years. Now, they are helping host #ISSAD2026.

Join us in Nairobi to bridge the gap between world-class research & life-saving policy.

#GBS #MaternalHealth
February 10, 2026 at 5:10 AM
Dr. Mandale’s current work is pivotal to #ISSAD2026 and the regulation of Group B streptococcus prevention. By supporting post-authorization monitoring, she ensures that regulatory decision-making is rooted in robust, real-world evidence.
February 9, 2026 at 3:08 PM